Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin 5 and B cell differentiation

K Takatsu1

  • 1Department of Immunology, Institute of Medical Science, University of Tokyo, Japan.

Cytokine & Growth Factor Reviews
|August 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study of X-ray topography using the super-Borrmann effect.

Journal of synchrotron radiation·2022
Same author

Expression of Heparin-Binding EGF-Like Growth Factor (HB-EGF) in Bovine Endometrium: Effects of HB-EGF and Interferon-τ on Prostaglandin Production.

Reproduction in domestic animals = Zuchthygiene·2015
Same author

Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice.

Diabetologia·2013
Same author

Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.

Leukemia·2009
Same author

Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone.

Journal of gastroenterology and hepatology·2002
Same author

Usefulness of endoscopic ultrasonography (EUS) in diagnosing esophageal infiltration of thyroid cancer.

Journal of endocrinological investigation·2001

Interleukin-5 (IL-5) signaling, crucial for B cells and eosinophils, involves specific receptor interactions and tyrosine kinases. Modulating IL-5 effects is vital for treating diseases like hypereosinophilic syndromes.

Area of Science:

  • Immunology
  • Cellular Signaling

Background:

  • Interleukin-5 (IL-5) is a key cytokine regulating B cell and eosinophil development.
  • The Interleukin-5 Receptor (IL-5R) complex consists of alpha and beta-common (βc) chains, mediating IL-5's biological functions.
  • Tyrosine kinases, including JAK2 and JAK1, are associated with IL-5R subunits and activated upon IL-5 stimulation.

Purpose of the Study:

  • To elucidate the molecular mechanisms of IL-5 signaling pathway.
  • To investigate the role of IL-5 in the context of immune-related diseases and potential therapeutic interventions.

Main Methods:

  • Analysis of IL-5 receptor (IL-5R) subunit interactions and associated kinase activation.
  • Investigation of protein tyrosine phosphorylations, including STAT5 and Bruton's tyrosine kinase (Btk), downstream of IL-5 stimulation.

Related Experiment Videos

  • Assessment of the functional significance of cytoplasmic proline-rich regions in IL-5Ralpha and βc chains.
  • Main Results:

    • IL-5 binding to IL-5Ralpha triggers βc recruitment and activation of JAK2/JAK1 kinases.
    • IL-5 stimulation leads to tyrosine phosphorylation of βc, STAT5, and activation of Btk.
    • Cytoplasmic proline-rich regions of IL-5Ralpha and βc are essential for IL-5 signal transduction.
    • Anti-IL-5 monoclonal antibody (mAb) treatment reduced allergen-induced bronchial hyperresponsiveness in animal models.

    Conclusions:

    • IL-5 signaling is a complex process involving specific receptor engagement, kinase activation, and downstream protein modifications.
    • IL-5 plays a significant role in hypereosinophilic syndromes and atopic diseases, suggesting therapeutic potential for anti-IL-5 strategies.
    • Understanding IL-5 signaling pathways provides targets for developing treatments for allergic and autoimmune conditions.